Taejoon Pharm's margin policy draws much flak

Published: 2003-06-27 06:56:00

Updated: 2003-06-27 06:56:00

Controversy is rising over an arbitrary notification by Taejoon Pharm, a leading eye drug maker in Korea, that the average wholesaler margin of an imported drug from Japan will be reduced by two percent from the current 7.5 percent level, industry observers said recently.

The Korea Drug Wholes...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK